Oncology (Cancer)
Prostate Cancer, Lung & Respiratory Cancers, Bladder Cancer, Kidney Cancer, Head & Neck Cancers, Leukemia & Lymphoma, Gastrointestinal Cancers, Skin Cancer / Melanoma
A cancer diagnosis raises two questions with the VA. Is it connected to your service, and what happens to your rating once treatment ends. Our licensed clinicians prepare nexus letters and independent medical opinions for both: presumptive claims under Agent Orange, the PACT Act, and Camp Lejeune, direct service connection, residual ratings after treatment, and 38 U.S.C. § 1151 claims where a VA facility delayed the diagnosis. We focus on the medicine. A confirmed diagnosis, a thorough explanation of exposure and causation, and reasoning grounded in your records and the medical literature.
About Oncology (Cancer) Claims
Most veteran cancers are not diagnosed in service. They show up 20, 30, sometimes 50 years later, when an old exposure finally becomes disease. Prostate cancer leads the list. Then come lung and other respiratory cancers, bladder and kidney cancers, head and neck cancers, the leukemias and lymphomas, GI cancers, and melanoma. Cancer claims differ from the rest of the VA system in two ways. Many carry presumptive pathways that remove the need to prove causation at all. And the rating itself follows a lifecycle unlike any other condition.
The presumptive lists are broader than most veterans realize. Agent Orange covers prostate cancer, respiratory cancers, bladder cancer, chronic B-cell leukemias, Hodgkin's and non-Hodgkin's lymphoma, and multiple myeloma, among others. The PACT Act goes further for burn pit exposure: respiratory cancers of any type, GI cancers of any type, head and neck cancers, brain cancer, kidney cancer, pancreatic cancer, melanoma, and lymphatic cancers. Camp Lejeune has its own list for anyone exposed to the base's water between 1953 and 1987, including kidney cancer, bladder cancer, liver cancer, and adult leukemia.
Here is the part that catches veterans off guard. Active cancer is generally rated 100%, and that rating holds for six months after treatment ends. Then the VA re-examines you and rates what remains. The residuals. Urinary incontinence, erectile dysfunction, chemo neuropathy, breathing problems, fatigue, and often depression. Each one is separately ratable. But the VA only rates what the record shows, so a residual that was never documented in rating terms simply vanishes from your rating. The months before that re-examination are when the documentation work matters most, and it is the stage where we see the most preventable losses.
No medical opinion can guarantee a VA outcome. What clear, credible, well-documented evidence can do is give the claim its strongest foundation. Our role is the medicine and the documentation. The decision on the claim rests with the VA.
Oncology (Cancer) Conditions
Click any condition to view its dedicated page with DC codes, rating criteria, secondary connections, and specialist guidance.
We are currently updating our list of specific conditions in this category. Contact us for a free consultation about your specific claim.
Why Oncology Claims Can Be Challenging
Understanding these challenges in advance is the first step toward building a clearer medical record — and knowing where additional evidence may help.
Decades-Long Latency
Cancer often appears 20 to 50 years after exposure. The presumptive framework absorbs that gap. Without it, the claim needs a medical explanation of latency, or the time gap becomes the VA's reason to deny.
The Rating Cliff After Treatment
The 100% rating ends six months after treatment. The re-exam rates only what the record shows. Undocumented residuals disappear from the rating.
Verifying the Exposure
Presumptions depend on where and when you served. When records are thin, exposure documentation decides the claim, not the medicine.
Residuals Across Body Systems
One prostate cancer can leave residuals in four systems. Urinary, sexual, neurological, psychological. Each rates under a different diagnostic code and needs its own documentation.
Non-Presumptive Cancer Types
When a cancer sits on no list, the claim needs a true causation opinion. Exposure characterization, latency analysis, literature support. A diagnosis alone gets denied.
The Need for Detailed Rationale
A conclusion alone carries little weight. The reasoning earns the credibility. The medical why, backed by literature and the record.
Medical Evidence Services for Oncology Claims
Clinician-led services support cancer claims at different stages. Each one focuses on the evidence: a confirmed diagnosis, sound exposure and causation reasoning, and residuals documented in rating terms.
Independent Medical Opinion / Nexus Letter
A clinician's written opinion on whether a condition is at least as likely as not connected to service, with the supporting medical rationale.
When you need to establish or strengthen the causal link — particularly for secondary claims or a claim that was previously denied.
t explains exposure and latency in plain English. Connects treatment residuals like neuropathy, ED, incontinence, and depression to the service-connected cancer. Supports 38 U.S.C. § 1151 analysis when a VA delay in diagnosis changed staging or prognosis.
Disability Benefits Questionnaire (DBQ)
Standardized disability questionnaires completed by licensed clinicians to evaluate the severity of your conditions according to VA rating criteria.
When you are filing for an initial rating, an increase, or need to document current functional impairment for a C&P exam.
It documents each residual against its own diagnostic code: voiding dysfunction, erectile dysfunction, pulmonary function, neuropathy findings, fatigue and functional limits. The post-cancer rating should reflect the full picture, not just the absence of active disease.
Claim Readiness Review
A pre-filing review of your medical records to identify what is already documented and what evidence may be missing.
Before filing or refiling, when you want a clear, honest picture of where a claim stands medically.
Pinpoints the gaps in your oncology record before you file. Missing pathology or staging documentation. Unverified exposure windows. Residuals nobody wrote down ahead of a re-examination. Presumptive eligibility nobody checked.
Veterans Usually Pair Oncology With These Systems
Oncology pairs most often with genitourinary (post-prostate residuals), pulmonology (respiratory cancers and lung function), mental health (depression secondary to cancer), and neurology (chemo-induced neuropathy).
Frequently Asked Questions
Yes, many cancers can. The link may be presumptive, like prostate cancer for Agent Orange exposure, respiratory and GI cancers under the PACT Act, or kidney and bladder cancers from Camp Lejeune water. It can also be direct, based on a documented in-service exposure or onset. A nexus letter explains the medical connection. The VA decides the claim.
Active cancer is rated 100% under the applicable diagnostic code. That rating continues for six months after treatment ends, whether that was surgery, chemotherapy, or radiation. Then the VA schedules an exam and re-rates the condition based on residuals, meaning the lasting effects of the cancer and its treatment. Think urinary incontinence, erectile dysfunction, neuropathy, breathing limits, and fatigue.
For qualifying burn pit and airborne hazard exposure, the PACT Act recognizes respiratory cancers of any type, gastrointestinal cancers of any type, head and neck cancers, brain cancer including glioblastoma, kidney cancer, pancreatic cancer, melanoma, lymphoma and lymphatic cancers, and reproductive cancers. Eligibility depends on your service locations and dates, which the VA verifies. Official list: VA.gov PACT Act.
Six months after active treatment concludes, the VA schedules a re-examination and re-rates the condition on residuals rather than the cancer itself. This is where many veterans lose ground. Residuals like urinary frequency, incontinence, erectile dysfunction, chemo-induced neuropathy, breathing impairment, and chronic fatigue are each separately ratable. But the VA only rates what the record shows in rating-criteria terms, so documentation needs to happen before the re-exam, not after the reduction.
Yes. Once the cancer is service connected, its treatment residuals are ratable conditions in their own right. Chemotherapy-induced peripheral neuropathy. Erectile dysfunction after prostate treatment, which can carry Special Monthly Compensation. Urinary incontinence, lymphedema, radiation tissue damage, and depression or anxiety tied to the cancer. Each residual should be documented against its own diagnostic code.
A delayed or missed cancer diagnosis at a VA facility may support a claim under 38 U.S.C. § 1151, which compensates additional disability caused by VA medical care. The medical opinion must establish what a competent provider would have done with the findings that were available, when the diagnosis reasonably should have been made, and how the delay changed the stage, the treatment options, or the prognosis. This is a separate pathway from service connection and it takes specialist-level analysis.
Veterans, family members, and others exposed to contaminated water at Camp Lejeune between 1953 and 1987 have recognized pathways for several cancers, including kidney cancer, bladder cancer, liver cancer, adult leukemia, and non-Hodgkin's lymphoma. VA disability presumptions and Camp Lejeune Justice Act claims are separate tracks. Medical evidence documenting the diagnosis and the exposure window supports both.
Cancer in remission is rated on residuals, not at the active-disease 100% level. A recurrence restores the active rating. The drop from active rating to residuals is steep, so for a veteran in remission the single most important evidence step is documenting every residual, physical and psychological, before the re-examination happens.
Yes. Mental health conditions that develop in response to a service-connected cancer, its treatment, or its lasting effects can be claimed as secondary conditions. The medical opinion documents the relationship between the cancer experience and the psychiatric diagnosis, which is then rated under the mental health criteria.
Not always. Presumptive claims often turn on exposure verification and residual documentation that an internal medicine physician can prepare. Oncology-level review earns its cost when the case is contested. A disputed diagnosis or staging question. A delayed-diagnosis 1151 analysis. A Board-level appeal where specialist authority matters. The right provider depends on the medical questions in your case, and we will tell you honestly which one that is.
A confirmed diagnosis with pathology, imaging, and staging. Evidence of qualifying exposure or in-service onset. Treatment records showing the course and the end date of active treatment. And documentation of residuals in rating-criteria terms. For 1151 delayed-diagnosis claims, the complete VA records surrounding the missed findings are essential.
It is the medical-evidentiary standard used in nexus opinions. It means the probability of a connection is at least 50 percent, as likely as not. A clinician uses it to state, in medical terms, whether a condition is reasonably connected to service. It is a medical opinion, not a legal determination.
A discovery call is a no-obligation conversation about your diagnosis, your exposure history, and your goals. We talk through the possible pathways, whether that is presumptive eligibility, direct connection, residuals, or a 1151 question, and explain whether additional medical evidence may help. There is no pressure to proceed. If we do not believe a letter would add value to your claim, we will say so.